Skip to main content

The Hydrodynamic Tail Vein Assay as a Tool for the Study of Liver Promoters and Enhancers

  • Protocol
  • First Online:
Pharmacogenomics

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1015))

Abstract

The hydrodynamic tail vein injection is a technique that is used to deliver nucleic acids into live mice. Delivery through this method results in the in vivo transfection of foreign DNA primarily in the liver. Here, we describe the use of this technique to test for regulatory activity of liver promoters and enhancers, using a dual luciferase reporter system as the readable/measureable output and how this application can be used for pharmacogenomic studies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zhang G, Budker V, Wolff JA (1999) High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 10:1735–1737

    Article  PubMed  CAS  Google Scholar 

  2. Eggenhofer E et al (2009) High volume naked DNA tail-vein injection restores liver function in Fah-knock out mice. Hepatology 25:1002–1008

    Google Scholar 

  3. Herweijer H, Zhang G et al (2001) Time course of gene expression after plasmid DNA gene transfer to the liver. J Gene Med 3(3):280–291

    Article  PubMed  CAS  Google Scholar 

  4. Herweijer H, Wolff JA (2003) Progress and prospects: naked DNA gene transfer and therapy. Gene Ther 10:453–458

    Article  PubMed  CAS  Google Scholar 

  5. Herweijer H, Wolff JA (2007) Gene therapy progress and prospects: hydrodynamic gene delivery. Gene Ther 14:99–107

    PubMed  CAS  Google Scholar 

  6. Lewis DL et al (2002) Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 32:107–108

    Article  PubMed  CAS  Google Scholar 

  7. McCaffrey AP et al (2002) RNA interference in adult mice. Nature 418:38–39

    Article  PubMed  CAS  Google Scholar 

  8. Sen A et al (2003) Inhibition of hepatitis C virus protein expression by RNA interference. Virus Res 96:27–35

    Article  PubMed  CAS  Google Scholar 

  9. Song E et al (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9:347–351

    Article  PubMed  CAS  Google Scholar 

  10. Zender L et al (2003) Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci USA 100:7797–7802

    Article  PubMed  CAS  Google Scholar 

  11. Xu J et al (2005) Reduction of PTP1B by RNAi upregulates the activity of insulin controlled fatty acid synthase promoter. Biochem Biophys Res Commun 329:538–543

    Article  PubMed  CAS  Google Scholar 

  12. Keng VW et al (2011) Modeling hepatitis B virus X-induced hepatocellular carcinoma in mice with the sleeping beauty transposon system. Hepatology 53:781–790

    Article  PubMed  CAS  Google Scholar 

  13. Zhou T et al (2010) Intracellular gene transfer in rats by tail vein injection of plasmid DNA. AAPS J 12:692–698

    Article  PubMed  CAS  Google Scholar 

  14. Chalasani N et al (2010) Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology 139:1567–1576

    Article  PubMed  Google Scholar 

  15. Zhang H et al (2010) Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 42:755–758

    Article  PubMed  CAS  Google Scholar 

  16. Chen WM et al (2008) Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest 118:2620–2628

    PubMed  CAS  Google Scholar 

  17. Schadt EE et al (2008) Mapping the genetic architecture of gene expression in human liver. PLoS Biol 6:1020–1032

    Article  CAS  Google Scholar 

  18. MIRUS, TransIT®-EE Hydrodynamic Delivery Solution Protocol. http://www.mirusbio.com/assets/cms_files/protocols/ML043.pdf. Accessed July 2011

  19. Choi JH et al (2009) Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1. Pharmacogenet Genomics 19:770–780

    Article  CAS  Google Scholar 

  20. Kim MJ et al (2011) Functional characterization of liver enhancers regulating drug-associated transporters. Clin Pharmacol Ther 89:571–578

    Article  PubMed  CAS  Google Scholar 

  21. Simonet WS et al (1993) A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J Biol Chem 268:8221–8229

    PubMed  CAS  Google Scholar 

  22. Caliper Life Sciences, IVIS® Lumina II. http://www.caliperls.com/products/preclinical-imaging/ivis-luminaii.htm. Accessed July 2011

  23. Promega Corporation, Dual-Luciferase® Reporter Assay Technical Manual. http://www.promega.com/resources/protocols/technical-manuals/0/dual-luciferase-reporter-assay-system-protocol/. Accessed July 2011

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Kim, M.J., Ahituv, N. (2013). The Hydrodynamic Tail Vein Assay as a Tool for the Study of Liver Promoters and Enhancers. In: Innocenti, F., van Schaik, R. (eds) Pharmacogenomics. Methods in Molecular Biology, vol 1015. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-435-7_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-435-7_18

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-434-0

  • Online ISBN: 978-1-62703-435-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics